SS Innovations International (SSII) Return on Capital Employed Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 252.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 23.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -110.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 49.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 658.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -231.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 200.00 |
| 10 | SS Innovations International | 770.31 Mn | 746.70 Mn | 5.33 Mn | 5,407.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,407.00 |
| Dec 31, 2025 | 13,644.00 |
| Sep 30, 2025 | 10,809.00 |
| Jun 30, 2025 | 8,483.00 |
| Mar 31, 2025 | 6,747.00 |
| Dec 31, 2024 | -7,283.00 |
| Sep 30, 2024 | -7,922.00 |
| Jun 30, 2024 | 69,044.00 |
| Mar 31, 2024 | 13,765.00 |
| Dec 31, 2023 | -15,598.00 |
| Sep 30, 2023 | -52,621.00 |
| Jun 30, 2023 | 72,277.00 |
| Mar 31, 2023 | 77,559.00 |
| Dec 31, 2022 | 163,639.00 |
| Sep 30, 2022 | 29,779.00 |
| Jun 30, 2022 | -170,483.00 |
| Mar 31, 2022 | -119,004.00 |
| Dec 31, 2021 | -168,744.00 |
| Sep 30, 2021 | 322.00 |
| Jun 30, 2021 | -9,350.00 |
| Mar 31, 2021 | -17,390.00 |
| Dec 31, 2020 | -21,294.00 |
| Sep 30, 2020 | -14,215.00 |
| Jun 30, 2020 | 4,173.00 |
| Mar 31, 2020 | 6,937.00 |
| Dec 31, 2019 | -18,698.00 |
| Sep 30, 2019 | -23,716.00 |
| Jun 30, 2019 | 392,180.00 |
| Mar 31, 2019 | 73,313.00 |
| Dec 31, 2018 | 128,387.00 |
| Sep 30, 2018 | 91,947.00 |